OncoMatch/Clinical Trials/NCT07230405
A Phase II Study of SKB571 in Patients With Lung Cancer
Is NCT07230405 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies SKB571 for for lung cancer (non-small cell).
Treatment: SKB571 for — This is a multicenter, phase II study. The purpose of this study is to evaluate the safety and preliminary anti-tumor activity of SKB571 in patients with advanced non-small cell lung cancer. Eligible subjects will receive SKB571 monotherapy, until radiographic disease progression, intolerable toxicity, discontinuation of study treatment required by the subject, or other protocol-specified treatment discontinuation criteria, whichever occurs first.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Non-Small Cell Lung Carcinoma
Disease stage
Metastatic disease required
locally advanced or metastatic NSCLC
Performance status
ECOG 0–1(Restricted strenuous activity)
Demographics
Prior therapy
Cannot have received: chemotherapy
Subjects who have received chemotherapy...within 4 weeks prior to the first dose of study treatment
Cannot have received: immunotherapy
Subjects who have received...immunotherapy...within 4 weeks prior to the first dose of study treatment
Cannot have received: biological therapy
Subjects who have received...biological therapy within 4 weeks prior to the first dose of study treatment
Lab requirements
Blood counts
Kidney function
Liver function
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07230405 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior chemotherapy, immunotherapy, biological therapy disqualifies patients from enrollment.
Is there an age limit?
Yes. Patients must be 75 years or younger.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages